Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2A Study of Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Patients After Cerebral Embolism

NCT01028794 is registered in ClinicalTrials.gov with National Cerebral and Cardiovascular Center, Japan as lead sponsor.

NCT NCT01028794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01028794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2A Study of Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Patients After Cerebral Embolism
Lead sponsor
National Cerebral and Cardiovascular Center, Japan
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2008
Completion date
July 31, 2013
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral embolism, stroke